Previous 10 | Next 10 |
Approval marks the first chemotherapy-free combination regimen for patients who have relapsed or did not respond to previous treatment Approval based on Phase 3 AUGMENT study, which showed the combination significantly improved median progression-free survival versus rituximab monother...
Empowering Investors To Make Informed Decisions. Seeking Alpha's mission is, " to empower investors to make informed decisions " . Here at Analysts' Corner, we believe demystifying the financial statements of corporations is a good start to the empowering process. Forget arguments on whethe...
This article is part of a series that provides an ongoing analysis of the changes made to Dan Loeb’s 13F stock portfolio on a quarterly basis. It is based on Third Point’s regulatory 13F Form filed on 05/15/2019. Please visit our Tracking Dan Loeb’s Third Point Portfoli...
Merger activity increased last week with three new deals announced, two pending deals closing and one deal terminated. Deal Statistics: New Deals: The acquisition of Isramco (ISRL) by Naphtha Israel Petroleum Corporation for $393.11 million or $121.40 per share in cash. The ...
Recently for those that trade M&A stocks it has been a case of arbageddon. So many current deals have hit potholes in one way or another. Spark Therapeutics ( ONCE ) has filed and then refiled their respective pre-merger notification and report forms to federal regulators an unusually hi...
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson's 13F stock portfolio on a quarterly basis. It is based on Paulson's regulatory 13F Form filed on 05/15/2019. Please visit our Tracking John Paulson's Pau13lson & Company Portfolio ser...
According to Aerpio Pharmaceuticals (ARPO) website, they are a bio pharmaceutical company focused on advancing first-in-class treatments for ocular diseases. Personally, I think the description is far too narrow and base my opinion on both the company's recent strong secondary readouts from ...
Source: BMS Website Empowering Investors To Make Informed Decisions. Seeking Alpha's mission is, " to empower investors to make informed decisions " . Here at Analysts' Corner, we believe demystifying the financial statements of corporations is a good start to the empowering process. ...
Higher short interest is an odd indicator in the market. On one hand, it's a good indicator of sentiment as a high level generally suggests skepticism of the company's outlook, bringing bears to expect eventually lower share prices. It's also a poor indicator because significant levels of shor...
“Brain Bulb” Hot Air Balloon Takes Flight in NYC Area to Elevate Importance of Brain Preservation Celgene Corporation (NASDAQ: CELG) and the Multiple Sclerosis Association of America (MSAA) today announced the launch of a new campaign, MS MindShift: A New View of MS ,...
News, Short Squeeze, Breakout and More Instantly...
Celgene Corporation Company Name:
CELG Stock Symbol:
NASDAQ Market:
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributor Brian Orelli analyzes Gilead 's (NASDAQ: GILD) earnings report and discusses why the biotech giant could see fairly low revenue growth or even see earnings dr...
What coronavirus? Amgen 's (NASDAQ: AMGN) latest set of quarterly figures, delivered Tuesday, showed growth in the company's fundamentals during a challenging time for companies across all economic sectors. The veteran biotech company booked revenue of nearly $6.21 billion in the second qu...
It's scary out there right now for investors, with wild market swings and a lot of negative news coming out of quarterly reports. There is one sector, however, that will survive and likely thrive despite the coronavirus pandemic shutdown -- healthcare. That said, investors shouldn't head for jus...